301333 诺思格
已收盘 04-15 15:00:00
资讯
新帖
简况
4月14日诺思格现12笔大宗交易 机构净买入506.64万元
证券之星 · 04-14 17:04
4月14日诺思格现12笔大宗交易 机构净买入506.64万元
诺思格：药石科技为创新药提供临床前服务，我公司为临床CRO公司
证券之星 · 04-03
诺思格：药石科技为创新药提供临床前服务，我公司为临床CRO公司
4月2日诺思格现5笔大宗交易 机构净买入525.64万元
证券之星 · 04-02
4月2日诺思格现5笔大宗交易 机构净买入525.64万元
股市必读：诺思格年报 - 第四季度单季净利润同比下降25.93%
证券之星 · 03-30
股市必读：诺思格年报 - 第四季度单季净利润同比下降25.93%
诺思格(301333)2月28日股东户数0.87万户，较上期减少2.87%
证券之星 · 03-28
诺思格(301333)2月28日股东户数0.87万户，较上期减少2.87%
图解诺思格年报：第四季度单季净利润同比下降25.93%
证券之星 · 03-28
图解诺思格年报：第四季度单季净利润同比下降25.93%
诺思格(301333.SZ)发布2025年度业绩，归母净利润1.37亿元，下降2.37%
智通财经 · 03-27
诺思格(301333.SZ)发布2025年度业绩，归母净利润1.37亿元，下降2.37%
3月27日诺思格现450.12万元大宗交易
证券之星 · 03-27
3月27日诺思格现450.12万元大宗交易
3月25日诺思格涨5.12%，信澳优享生活混合A基金重仓该股
证券之星 · 03-25
3月25日诺思格涨5.12%，信澳优享生活混合A基金重仓该股
诺思格（301333）披露部分募投项目延期及内部投资结构调整公告，3月17日股价下跌5.25%
证券之星 · 03-17
诺思格（301333）披露部分募投项目延期及内部投资结构调整公告，3月17日股价下跌5.25%
诺思格最新公告：“临床试验管理平台”项目延期
证券之星 · 03-17
诺思格最新公告：“临床试验管理平台”项目延期
3月17日诺思格跌5.25%，信澳优享生活混合A基金重仓该股
证券之星 · 03-17
3月17日诺思格跌5.25%，信澳优享生活混合A基金重仓该股
诺思格（301333）披露2025年度持续督导培训情况报告，3月13日股价下跌2.79%
证券之星 · 03-13
诺思格（301333）披露2025年度持续督导培训情况报告，3月13日股价下跌2.79%
诺思格最新公告：股东拟合计减持不超1.99%股份
证券之星 · 03-03
诺思格最新公告：股东拟合计减持不超1.99%股份
2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股
证券之星 · 02-03
2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股
诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%
证券之星 · 02-02
诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%
诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%
证券之星 · 01-27
诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%
1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股
证券之星 · 01-23
1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股
诺思格涨5.13%，太平洋二个月前给出“买入”评级
证券之星 · 01-23
诺思格涨5.13%，太平洋二个月前给出“买入”评级
1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股
证券之星 · 01-16
1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股
加载更多
公司概况
公司名称：
诺思格(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-08-02
主营业务：
诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是临床试验运营服务、临床试验现场管理服务、数据管理与统计分析服务、生物样本检测服务、临床试验咨询服务、临床药理学服务。
发行价格：
78.88
{"stockData":{"symbol":"301333","market":"SZ","secType":"STK","nameCN":"诺思格","latestPrice":69.26,"timestamp":1776236586000,"preClose":68.47,"halted":0,"volume":2593900,"delay":0,"changeRate":0.0115,"floatShares":96443700,"shares":96581299,"eps":1.3831,"marketStatus":"已收盘","change":0.79,"latestTime":"04-15 15:00:00","open":69.37,"high":70.24,"low":66.71,"amount":178000000,"amplitude":0.0516,"askPrice":69.26,"askSize":55,"bidPrice":69.25,"bidSize":11,"shortable":0,"etf":0,"ttmEps":1.3831,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":5,"adr":0,"adjPreClose":68.47,"symbolType":"stock","openAndCloseTimeList":[[1776216600000,1776223800000],[1776229200000,1776236400000]],"highLimit":75.32,"lowLimit":61.62,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":96581256,"isCdr":false,"pbRate":3.36,"roa":"--","peRate":50.075916,"roe":"7.21%","epsLYR":1.43,"committee":-0.358601,"marketValue":6689000000,"turnoverRate":0.0269,"status":0,"floatMarketCap":6680000000},"requestUrl":"/m/hq/s/301333","defaultTab":"news","newsList":[{"id":"2627069419","title":"4月14日诺思格现12笔大宗交易 机构净买入506.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627069419","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627069419?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:04","pubTimestamp":1776157462,"startTime":"0","endTime":"0","summary":"证券之星消息，4月14日诺思格发生大宗交易，交易数据如下：近三个月该股共发生18笔大宗交易，合计成交1.07万手，折价成交17笔，溢价成交1笔。该股在过去半年内已有共计3926.88万股限售解禁股上市，占公司总股本的40.66%。截至2026年4月14日收盘，诺思格(301333)报收于68.47元，上涨3.38%，换手率2.05%，成交量1.97万手，成交额1.33亿元。该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为74.0。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400027150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624635027","title":"诺思格：药石科技为创新药提供临床前服务，我公司为临床CRO公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2624635027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624635027?lang=zh_cn&edition=full","pubTime":"2026-04-03 08:36","pubTimestamp":1775176572,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：1.药石科技在分子砌块、连续流工艺、ADC/TPD关键中间体等领域具备国内独一档的技术壁垒，也是很多创新药公司早期研发和CMC开发的重要合作伙伴。药石科技为创新药提供临床前服务，我公司为临床CRO公司，具体业务情况请详见公司定期报告“管理层讨论与分析”章节，两者方向不同。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300009094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK1161","BK0229","06978","BK1574","159992","300725","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624574239","title":"4月2日诺思格现5笔大宗交易 机构净买入525.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624574239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624574239?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:01","pubTimestamp":1775120478,"startTime":"0","endTime":"0","summary":"证券之星消息，4月2日诺思格发生大宗交易，交易数据如下：近三个月该股共发生6笔大宗交易，合计成交2618.0手，折价成交5笔，溢价成交1笔。该股在过去半年内已有共计3926.88万股限售解禁股上市，占公司总股本的40.66%。截至2026年4月2日收盘，诺思格(301333)报收于69.47元，下跌3.02%，换手率4.0%，成交量3.86万手，成交额2.63亿元。该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为74.0。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200028231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623509903","title":"股市必读：诺思格年报 - 第四季度单季净利润同比下降25.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623509903","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623509903?lang=zh_cn&edition=full","pubTime":"2026-03-30 03:25","pubTimestamp":1774812314,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告诺思格2025年全年主营收入8.51亿元，同比增长14.38%；归母净利润1.37亿元，同比下降2.37%；扣非净利润1.13亿元，同比下降1.47%。2025年第四季度单季主营收入2.44亿元，同比增长33.81%；单季归母净利润4133.28万元，同比下降25.93%；单季扣非净利润3126.78万元，同比下降34.68%。该说明仅用于年度报告披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622732385","title":"诺思格(301333)2月28日股东户数0.87万户，较上期减少2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622732385","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622732385?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:07","pubTimestamp":1774688833,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诺思格披露，截至2026年2月28日公司股东户数为8663.0户，较12月31日减少256.0户，减幅为2.87%。在医疗服务行业个股中，诺思格股东户数低于行业平均水平，截至2月28日，医疗服务行业平均股东户数为4.5万户。从股价来看，2025年12月31日至2026年2月28日，诺思格区间涨幅为23.93%，在此期间股东户数减少256.0户，减幅为2.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622744378","title":"图解诺思格年报：第四季度单季净利润同比下降25.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622744378","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622744378?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:38","pubTimestamp":1774633099,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格2025年年报显示，当年度公司主营收入8.51亿元，同比上升14.38%；归母净利润1.37亿元，同比下降2.37%；扣非净利润1.13亿元，同比下降1.47%；其中2025年第四季度，公司单季度主营收入2.44亿元，同比上升33.81%；单季度归母净利润4133.28万元，同比下降25.93%；单季度扣非净利润3126.78万元，同比下降34.68%；负债率17.66%，投资收益1014.84万元，财务费用-469.31万元，毛利率34.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800003738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622824283","title":"诺思格(301333.SZ)发布2025年度业绩，归母净利润1.37亿元，下降2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622824283","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622824283?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:08","pubTimestamp":1774616892,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)发布2025年年度报告，该公司营业收入为8.51亿元，同比增长14.38%。归属于上市公司股东的净利润为1.37亿元，同比减少2.37%。归属于上市公司股东的扣除非经常性损益的净利润为1.13亿元，同比减少1.47%。基本每股收益为1.43元。此外，拟向全体股东每10股派发现金红利1.60元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"诺思格(301333.SZ)发布2025年度业绩，归母净利润1.37亿元，下降2.37%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622417308","title":"3月27日诺思格现450.12万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2622417308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622417308?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:02","pubTimestamp":1774602133,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日诺思格发生大宗交易，交易数据如下：大宗交易成交价格68.2元，相对当日收盘价溢价9.77%，成交6.6万股，成交金额450.12万元，买方营业部为中银国际证券股份有限公司上海虹口区东长治路证券营业部，卖方营业部为方正证券股份有限公司成都抚琴西路证券营业部。近三个月该股共发生1笔大宗交易，合计成交660.0手，溢价成交1笔。截至2026年3月27日收盘，诺思格报收于62.13元，上涨3.41%，换手率2.31%，成交量2.23万手，成交额1.37亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700034731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622025944","title":"3月25日诺思格涨5.12%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622025944?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:28","pubTimestamp":1774427282,"startTime":"0","endTime":"0","summary":"证券之星消息，3月25日诺思格涨5.12%，收盘报59.9元，换手率2.77%，成交量2.67万手，成交额1.6亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500030715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1237","01717","BK1500","BK1597","BK1553","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620473762","title":"诺思格（301333）披露部分募投项目延期及内部投资结构调整公告，3月17日股价下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473762?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:27","pubTimestamp":1773757638,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，诺思格报收于61.2元，较前一交易日下跌5.25%，最新总市值为59.11亿元。该股当日开盘64.59元，最高64.99元，最低61.14元，成交额达1.28亿元，换手率为2.11%。公告显示，公司于2026年3月17日召开董事会，审议通过部分募投项目延期及内部投资结构调整的议案。募投项目“临床试验管理平台”预计完成日期由2026年8月延期至2028年8月。本次调整未改变实施主体、实施方式、募集资金用途及投资规模，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","000860.SH","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620842843","title":"诺思格最新公告：“临床试验管理平台”项目延期","url":"https://stock-news.laohu8.com/highlight/detail?id=2620842843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620842843?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:49","pubTimestamp":1773740985,"startTime":"0","endTime":"0","summary":"诺思格公告称，在募投项目实施主体、方式、用途及规模不变的前提下，对“临床试验管理平台”项目延期，预计完成日期由2026年8月调整至2028年8月；同时对“临床试验管理平台”和“SMO中心项目”的内部投资结构进行调整，原投资计划金额中设备购置费、工程建设费用、人员费用可减少，增加相关软件及技术应用的投入，有利于提高临床运营服务的效率与质量，并推动公司的整体发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700032435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620444031","title":"3月17日诺思格跌5.25%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620444031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620444031?lang=zh_cn&edition=full","pubTime":"2026-03-17 16:14","pubTimestamp":1773735293,"startTime":"0","endTime":"0","summary":"证券之星消息，3月17日诺思格跌5.25%，收盘报61.2元，换手率2.11%，成交量2.04万手，成交额1.28亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700027171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1553","BK0216","01717","BK1500","BK1597","BK1237","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619811522","title":"诺思格（301333）披露2025年度持续督导培训情况报告，3月13日股价下跌2.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619811522","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619811522?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:48","pubTimestamp":1773413301,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，诺思格报收于64.84元，较前一交易日下跌2.79%，最新总市值为62.62亿元。该股当日开盘66.71元，最高66.98元，最低64.52元，成交额达7449.21万元，换手率为1.18%。近日，诺思格披露《中国国际金融股份有限公司关于诺思格（北京）医药科技股份有限公司2025年度持续督导培训情况的报告》。公告显示，中国国际金融股份有限公司根据相关监管要求，对诺思格的控股股东、实际控制人、董事、高级管理人员及关键岗位人员开展了2025年度持续督导培训。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300041983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616891340","title":"诺思格最新公告：股东拟合计减持不超1.99%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616891340","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616891340?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:39","pubTimestamp":1772541570,"startTime":"0","endTime":"0","summary":"诺思格(301333.SZ)公告称，持股5%以上股东宁波康运福股权投资有限公司、宁波瑞光创业投资合伙企业（有限合伙）及特定股东宁波瑞明股权投资有限公司（三者为一致行动人），因自身资金需求，计划自公告披露之日起15个交易日后的3个月内，通过大宗交易方式合计减持不超过181.93万股，占公司总股本的1.99%（其中康运福公司减持不超过108.8万股、占1.13%，瑞光合伙企业减持不超过12.73万股、占0.13%，瑞明公司减持不超过70.4万股、占0.73%）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300041559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608182693","title":"2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608182693","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608182693?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:50","pubTimestamp":1770108659,"startTime":"0","endTime":"0","summary":"证券之星消息，2月3日诺思格涨8.76%，收盘报78.98元，换手率4.48%，成交量4.32万手，成交额3.32亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300028357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK1553","01717","BK0216","BK1597","BK1500","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608871368","title":"诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871368","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608871368?lang=zh_cn&edition=full","pubTime":"2026-02-02 08:02","pubTimestamp":1769990534,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，诺思格于2月2日将有3926.88万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本40.66%。本次解禁后，公司还有13.75万股限售股份，占总股本0.14%。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606780765","title":"诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780765","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780765?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:24","pubTimestamp":1769523863,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，诺思格报收于70.25元，较前一交易日下跌0.87%，最新总市值为67.85亿元。诺思格（北京）医药科技股份有限公司于2026年1月27日发布《关于首次公开发行前已发行股份解除限售并上市流通的提示性公告》。本次解除限售的股份上市流通日期为2026年2月2日。上述股东均已履行相关股份锁定承诺，本次解除限售股份不存在质押或冻结情形。本次解除限售后，公司有限售条件股份减少至137,520股，无限售条件股份相应增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605160422","title":"1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605160422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605160422?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:47","pubTimestamp":1769154420,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日诺思格涨5.13%，收盘报73.6元，换手率7.51%，成交量4.29万手，成交额3.11亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300020073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1500","01717","BK1597","BK1553","BK1237","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605121422","title":"诺思格涨5.13%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2605121422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605121422?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:46","pubTimestamp":1769154413,"startTime":"0","endTime":"0","summary":"今日诺思格涨5.13%，收盘报73.6元。2025年10月31日，太平洋研究员周豫,张崴发布了对诺思格的研报《Q3收入稳健增长，利润增速超预期》，该研报对诺思格给出“买入”评级。研报中预计2025年-2027年公司营收为7.76/8.52/9.69亿元，同比增长4.33%/9.75%/13.79%；归母净利为1.50/1.63/1.81亿元，同比增长6.85%/8.83%/11.26%，对应PE为33/31/28倍，持续给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的周豫、张崴。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300020069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301333"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603968222","title":"1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603968222?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:43","pubTimestamp":1768549387,"startTime":"0","endTime":"0","summary":"证券之星消息，1月16日诺思格跌5.15%，收盘报72.08元，换手率8.56%，成交量4.9万手，成交额3.58亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600019566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1237","301333","BK1500","BK1597","01717","BK0216","BK1553"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776282084327,"stockEarnings":[{"period":"1week","weight":0.0229},{"period":"1month","weight":0.0723},{"period":"3month","weight":-0.0886},{"period":"6month","weight":0.3824},{"period":"1year","weight":0.5343},{"period":"ytd","weight":0.1631}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0208},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诺思格(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"8663人(较上一季度减少2.87%)","perCapita":"11132股","listingDate":"2022-08-02","address":"北京市通州区经济开发区东区创益西路518号","registeredCapital":"9658万元","survey":" 诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是临床试验运营服务、临床试验现场管理服务、数据管理与统计分析服务、生物样本检测服务、临床试验咨询服务、临床药理学服务。","listedPrice":78.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺思格,301333,诺思格股票,诺思格股票老虎,诺思格股票老虎国际,诺思格行情,诺思格股票行情,诺思格股价,诺思格股市,诺思格股票价格,诺思格股票交易,诺思格股票购买,诺思格股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}